Medication info

Montelukast Granules 4mg (Montelukast Sodium)

Prescription medicationOralApproval withdrawn
Ingredient · strength
Montelukast Sodium›4.16mg / 1 packet
Manufacturer / importer
NBK Pharmaceutical Co., Ltd.
Appearance
Homogeneous white granules without impurities
Packaging
4mg/packet, 4mg/packet x 28
Approval status
Approval withdrawn

MFDS item code 202002914 · Approved 2020.04.23

This product's status changed to Approval withdrawn on 2024.07.25. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Prevention and treatment of asthma; relief of seasonal and perennial allergic rhinitis symptoms
Who takes it
Adults · Children
Adult dose
This medicine is taken once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the time of administration should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 packet once daily in the evening. ○ How to take the fine granules The 4 mg fine granules may be taken orally directly or mixed with a small amount (about 5 mL) of soft food at or below room temperature, such as infant food, breast milk, or porridge. Do not open the package until immediately before use. After opening, immediately (within 15 minutes) mix the contents with infant food, breast milk, or food, or take the entire contents directly. Do not leave this medicine mixed with infant food, breast milk, or food for an extended period; discard any remainder. This formulation is not intended to be mixed with beverages other than infant food or breast milk, but a beverage may be taken immediately after administration. This medicine may be taken without regard to meals.
Child dose
Asthma Children 2~5 years: Administer montelukast 4 mg orally once daily. Infants 12 months to under 2 years: Administer this medicine 4 mg orally once daily in the evening. The efficacy and safety of this medicine for asthma have not been established in infants under 12 months of age. Allergic rhinitis Children 2~5 years: Administer montelukast 4 mg orally once daily. The efficacy and safety of this medicine for seasonal allergic rhinitis have not been established in infants under 2 years of age. Infants 6 months to under 2 years: Administer this medicine 4mg orally once daily. The efficacy and safety of this medicine for perennial allergic rhinitis have not been established in infants under 6 months of age.

Ingredients

Manufacturer
NBK Pharmaceutical Co., Ltd.

Efficacy & effects

Prevention and treatment of asthma; relief of seasonal and perennial allergic rhinitis symptoms

  • Asthma
  • allergic rhinitis symptoms
View approved original text

This medication is used to prevent asthma and assist in continued treatment. It is also used to alleviate the symptoms of seasonal and perennial allergic rhinitis.

How to take

Adult dose

This medicine is taken once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the time of administration should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 packet once daily in the evening. ○ How to take the fine granules The 4 mg fine granules may be taken orally directly or mixed with a small amount (about 5 mL) of soft food at or below room temperature, such as infant food, breast milk, or porridge. Do not open the package until immediately before use. After opening, immediately (within 15 minutes) mix the contents with infant food, breast milk, or food, or take the entire contents directly. Do not leave this medicine mixed with infant food, breast milk, or food for an extended period; discard any remainder. This formulation is not intended to be mixed with beverages other than infant food or breast milk, but a beverage may be taken immediately after administration. This medicine may be taken without regard to meals.

Child dose

Asthma Children 2~5 years: Administer montelukast 4 mg orally once daily. Infants 12 months to under 2 years: Administer this medicine 4 mg orally once daily in the evening. The efficacy and safety of this medicine for asthma have not been established in infants under 12 months of age. Allergic rhinitis Children 2~5 years: Administer montelukast 4 mg orally once daily. The efficacy and safety of this medicine for seasonal allergic rhinitis have not been established in infants under 2 years of age. Infants 6 months to under 2 years: Administer this medicine 4mg orally once daily. The efficacy and safety of this medicine for perennial allergic rhinitis have not been established in infants under 6 months of age.

Precautions

This medication should not be used in patients allergic to this medication or its components. Fatigue, fever, abdominal pain, dizziness, headache, nasal congestion, cough, rash, and other symptoms may occur during treatment, so caution is advised. Especially in children and adolescents, various adverse reactions such as pharyngitis, influenza, fever, nausea, diarrhea, loss of appetite, and otitis media have been reported, so if symptoms occur, consult a doctor. This medication is not for treating acute asthma attacks; immediate emergency treatment is necessary during acute symptoms, and emergency inhalers should always be on hand. Do not abruptly discontinue inhaled corticosteroids or substitute with this medication; follow your doctor's instructions to gradually reduce the dose. Neuropsychiatric symptoms such as anxiety, agitation, depression, hallucinations, and suicidal thoughts may occur during treatment, so inform your doctor immediately if such symptoms occur. If bronchospasm triggered by exercise occurs, do not treat it only with this medication; continue using inhaled beta-agonists. Patients with hypersensitivity to aspirin or non-steroidal anti-inflammatory drugs should avoid those medications while taking this drug. Rarely, systemic eosinophilia and vasculitis symptoms may appear in asthma patients on this medication, so if symptoms such as eosinophilia, skin rash, or worsening respiratory symptoms occur, seek medical attention. Interactions with other medications are minimal, but caution is needed when taken with certain liver enzyme inducers, so consult your doctor or pharmacist. If pregnant or breastfeeding, avoid use unless clearly necessary, and discuss with a doctor before taking. This medication is intended for use by children and the elderly, but safety and efficacy have not been established in infants under 6 months. In case of overdose, there is no specific antidote, so seek proper medical treatment immediately, and general symptom management is required. Since it is sensitive to light, do not open the packaging until just before administration, and it is best to take it immediately after opening. Store in a place out of reach of children, and do not transfer to other containers. This medication should be taken consistently even if asthma symptoms are absent, and you must consult a doctor if symptoms worsen.

Side effects

  • Asthenia
  • fatigue
  • fever
  • abdominal pain
  • trauma
  • dyspepsia
  • infectious gastroenteritis
  • toothache
  • dizziness
  • headache
Show 90 more
  • nasal congestion
  • cough
  • influenza
  • rash
  • increased ALT
  • increased AST
  • pyuria
  • pharyngitis
  • sinusitis
  • nausea
  • diarrhea
  • loss of appetite
  • otitis
  • viral infection
  • laryngitis
  • (infectious) rhinitis
  • chickenpox
  • gastroenteritis
  • atopic dermatitis
  • acute bronchitis
  • dental infection
  • skin infection
  • myopia
  • runny nose
  • ear pain
  • gastroenteritis
  • eczema
  • urticaria
  • pneumonia
  • dermatitis
  • conjunctivitis
  • upper respiratory tract infection
  • wheezing
  • otitis media
  • tonsillitis
  • sinusitis
  • headache
  • epistaxis
  • increased frequency of bleeding
  • thrombocytopenia
  • hypersensitivity
  • aggressive behavior
  • hostility
  • restlessness
  • anxiety
  • depression
  • orientation disorder
  • attention disorder
  • sleep disorder
  • hallucinations
  • insomnia
  • memory disorder
  • psychomotor hyperactivity
  • sleepwalking
  • suicidal ideation
  • behavioral disorder
  • tic
  • drowsiness
  • perceptual distortion
  • sensory impairment
  • convulsions
  • palpitations
  • pulmonary eosinophilia
  • diarrhea
  • vomiting
  • pancreatitis
  • cholestatic hepatitis
  • hepatocellular liver damage
  • mixed liver damage
  • angioedema
  • bruising
  • erythema multiforme
  • nodular erythema
  • pruritus
  • urticaria
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • arthralgia
  • muscle spasms
  • myalgia
  • nocturnal enuresis
  • edema
  • systemic eosinophilia
  • vasculitis rash
  • worsening pulmonary symptoms
  • cardiac complications
  • neuropathy
  • alopecia
  • thirst
  • psychomotor agitation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to moisture and light, so it should be stored at room temperature between 1°C and 30°C. Additionally, when not in use, it is important to tightly close the lid to prevent air from entering.

Appearance and packaging

Appearance

Homogeneous white granules without impurities

Package unit

4mg/packet, 4mg/packet x 28

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.